INARI MEDICAL INC. - COMMON STOCK

Inari Medical Announces Launch of 2021 Ethos and Sustainability Report

13 May 2022 16:01:00 By Nasdaq GlobeNewswire

Inari Medical Reports First Quarter 2022 Financial Results

04 May 2022 16:01:00 By Nasdaq GlobeNewswire

Inari Medical to Present at the Bank of America 2022 Healthcare Conference

28 Apr 2022 16:01:00 By Nasdaq GlobeNewswire

Inari Medical to Announce First Quarter 2022 Financial Results

20 Apr 2022 16:01:00 By Nasdaq GlobeNewswire

Inari Medical Announces Closing of Underwriters’ Over-Allotment Option in Connection with Offering of Common Stock

21 Mar 2022 17:27:23 By Nasdaq GlobeNewswire

Inari Medical Announces Pricing of Offering of Common Stock

10 Mar 2022 21:07:27 By Nasdaq GlobeNewswire

Inari Medical Announces Proposed Offering of Common Stock

10 Mar 2022 07:33:08 By Nasdaq GlobeNewswire

Inari Medical Appoints Robert Warner to Board of Directors

01 Mar 2022 08:00:18 By Nasdaq GlobeNewswire

Inari Medical Reports Fourth Quarter and Full Year 2021 Financial Results

23 Feb 2022 16:01:00 By Nasdaq GlobeNewswire

Inari Medical Announces First Patient Enrolled in the PEERLESS Trial, a Randomized Controlled Trial Evaluating Outcomes of the FlowTriever® System in Pulmonary Embolism Patients

15 Feb 2022 08:00:02 By Nasdaq GlobeNewswire

Inari Medical to Announce Fourth Quarter and Full-Year 2021 Financial Results

10 Feb 2022 16:01:00 By Nasdaq GlobeNewswire

Inari Medical to Present at Upcoming Investor Conferences

01 Feb 2022 16:01:00 By Nasdaq GlobeNewswire

Inari Medical Reports Preliminary Fourth Quarter 2021 Revenue

10 Jan 2022 16:01:00 By Nasdaq GlobeNewswire

Inari Medical to Present at the 40th Annual J.P. Morgan Healthcare Conference

29 Dec 2021 16:01:00 By Nasdaq GlobeNewswire

Inari Medical Reports Third Quarter 2021 Financial Results

09 Nov 2021 16:01:01 By Nasdaq GlobeNewswire

Inari Medical Announces 6-month FLASH Registry Interim Data Demonstrating Benefits of Lytic-Free Mechanical Thrombectomy in 500 Real-World PE Patients

28 Oct 2021 08:01:00 By Nasdaq GlobeNewswire

Inari Medical to Announce Third Quarter 2021 Financial Results

26 Oct 2021 16:01:00 By Nasdaq GlobeNewswire

Inari Medical Announces Randomized Controlled Trial Evaluating Clinical Outcomes of the FlowTriever® System in Pulmonary Embolism Patients

18 Oct 2021 08:00:00 By Nasdaq GlobeNewswire

Inari Medical Appoints Dana G. Mead, Jr. to Board of Directors

01 Oct 2021 08:00:01 By Nasdaq GlobeNewswire

Inari Medical Appoints Pulmonologist Dr. Victor F. Tapson as VP of Medical Affairs

21 Sep 2021 08:00:01 By Nasdaq GlobeNewswire